试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
1200×800
www.ophthalmologytimes.com
Alcon reveals final data from Vivity Registry Study which demonstrat…
1280×720
www.ophthalmologytimes.com
Researchers receive $6.4 million grant from NEI to seek new treatment for blind…
3332×1850
www.ophthalmologytimes.com
Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-…
3800×2533
www.ophthalmologytimes.com
ASCRS 2023: New head-to-head data show monofocal IOLs provid…
1272×708
www.ophthalmologytimes.com
EyeBio announces positive data from first-in-human Ph1b/2a AMARONE trial of Restoret for DME, DVAMD
2524×1422
www.ophthalmologytimes.com
OKYO Pharma announces final patient in OK-101 trial for dry eye disease completed dosing study
1920×1080
www.ophthalmologytimes.com
Johnson & Johnson launches TECNIS Odyssey IOL in US
1280×720
www.ophthalmologytimes.com
Johnson & Johnson launches TECNIS Odyssey IOL in US
1920×1080
www.ophthalmologytimes.com
LumiThera announces sustained vision improvement for 24 months in dry AMD clinical t…
1920×1039
www.ophthalmologytimes.com
Aviceda begins part 2 of Phase II/III trial for geographic atrophy
1200×800
www.ophthalmologytimes.com
FDA gives IND clearance to OKYO Pharma for OK-101 in n…
1200×800
www.ophthalmologytimes.com
Nicox publishes results of Phase 3 trial of NCX 470 for treatment …
1280×720
www.ophthalmologytimes.com
enVista Envy by Bausch + Lomb approved by Health Canada
1280×720
www.ophthalmologytimes.com
Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi
1200×718
www.ophthalmologytimes.com
Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi
1280×720
www.ophthalmologytimes.com
Orasis Pharmaceuticals completes $78 million financing to support commercial launch of Qlosi
1200×800
www.ophthalmologytimes.com
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no matter what they do on TikTok
1280×720
www.ophthalmologytimes.com
Aviceda begins part 2 of Phase II/III trial for geographic atrophy
1920×1080
www.ophthalmologytimes.com
Study: Eating grapes may benefit eye health
2436×1492
www.ophthalmologytimes.com
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and F…
2538×1428
www.ophthalmologytimes.com
Orasis Pharmaceuticals completes $78 million financing to support commerci…
1280×720
www.ophthalmologytimes.com
Dean McGee Eye Institute continues tradition of leadership in patient care, education and vision ...
1200×812
www.ophthalmologytimes.com
A guide to treating severe ocular graft-vs-host disease
3198×1734
www.ophthalmologytimes.com
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis ...
1280×720
www.ophthalmologytimes.com
Apellis partnering with actor Henry Winkler to bring happy days to fight against geographic atrophy
3840×2552
www.ophthalmologytimes.com
Apellis partnering with actor Henry Winkler to bring happy days to fight against geograph…
1678×941
www.ophthalmologytimes.com
Apellis partnering with actor Henry Winkler to bring happy days to fight against geographic atrophy
1920×1080
www.ophthalmologytimes.com
Apellis partnering with actor Henry Winkler to bring happy days to fight against geographi…
1080×1080
www.ophthalmologytimes.com
Beezin’: The hazardous TikTok trend involving …
1200×800
www.ophthalmologytimes.com
Tools can detect corneal nerve damage early
1200×800
www.ophthalmologytimes.com
Eyedaptic unveils EYE6 with Ivy, an AI-powered visual assistant for pati…
1668×929
www.ophthalmologytimes.com
New EndoGlide technique in treatment for Fuchs’ dystrophy shows promise
1200×900
www.ophthalmologytimes.com
Dry eye paradise: FDA green-lights Miebo as first and only eye drop app…
1200×673
www.ophthalmologytimes.com
Dry eye paradise: FDA green-lights Miebo as first and only eye drop approved for t…
1000×667
www.ophthalmologytimes.com
Dry eye paradise: FDA green-lights Miebo as first and only ey…
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
Invisible focusable element for fixing accessibility issue
反馈
反馈
